Form D · Hedge Fund

Leerink Pharmaceutical Fund LP

Boston, MA · CIK 0001610059

Offering snapshot reported Dec 6, 2017 · SEC filing

Reported sold: $83.5M
Investors reported: 11
Minimum accepted: $0
First sale: Jul 1, 2014

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 6, 2017	Amendment	$83,501,000	$0vs Jun 23, 2017	11	SEC filing
Jun 23, 2017	Amendment	$83,501,000	$0vs Jun 24, 2016	11	SEC filing
Jun 24, 2016	Amendment	$83,501,000	$38,000,000vs Jun 26, 2015	7	SEC filing
Jun 26, 2015	Amendment	$45,501,000	No comparison	3	SEC filing
Jun 27, 2014	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-219920

Source: Form D, filed Dec 6, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

LEERINK PHARMACEUTICAL FUND LP

Investment adviser: LEERINK PHARMACEUTICAL INVESTMENTS LLC

Gross asset value: $10K
Beneficial owners: 6
ADV minimum commitment: $1M

Reported in Form ADV on Dec 14, 2017. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALPS FUND SERVICES BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor BDO USA LLP BOSTON, Massachusetts, United States

Custodian FIRST REPUBLIC BANK BOSTON, Massachusetts, United States Related to adviser: No

Custodian NORTHERN TRUST COMPANY CHICAGO, Illinois, United States Related to adviser: No

Marketer FREEMAN & CO. SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Marketer LEERINK PARTNERS LLC BOSTON, Massachusetts, United States Related to adviser: Yes

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

BDO USA LLP
PCAOB 243

FREEMAN & CO. SECURITIES LLC
CRD 118939 · SEC 8-53700

LEERINK PARTNERS LLC
CRD 39011 · SEC 8-48535

Filing source

Form ADV 1155614 · Dec 14, 2017 · Schedule D 7.B.(1), fund 805-4096465398

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Gp Lp Leerink Pharmaceutical Fund	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

One Federal Street 25 Th Floor
Boston, MA, 02110